关注
Takefumi Kimura
Takefumi Kimura
在 shinshu-u.ac.jp 的电子邮件经过验证
标题
引用次数
引用次数
年份
Current status, problems, and perspectives of non-alcoholic fatty liver disease research
N Tanaka, T Kimura, N Fujimori, T Nagaya, M Komatsu, E Tanaka
World journal of gastroenterology 25 (2), 163, 2019
1552019
Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein level predicts liver fibrosis and prognosis in primary biliary cirrhosis
T Umemura, S Joshita, T Sekiguchi, Y Usami, S Shibata, T Kimura, ...
Official journal of the American College of Gastroenterology| ACG 110 (6 …, 2015
1462015
Vonoprazan‐Based Regimen Is More Useful than PPI‐Based One as a First‐Line Helicobacter pylori Eradication: A Randomized Controlled Trial
M Maruyama, N Tanaka, D Kubota, M Miyajima, T Kimura, K Tokutake, ...
Canadian Journal of Gastroenterology and Hepatology 2017 (1), 4385161, 2017
812017
Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARα
M Komatsu, T Kimura, M Yazaki, N Tanaka, Y Yang, T Nakajima, ...
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1852 (3), 473-481, 2015
762015
Human leukocyte antigen class II haplotypes affect clinical characteristics and progression of type 1 autoimmune hepatitis in Japan
T Umemura, Y Katsuyama, K Yoshizawa, T Kimura, S Joshita, M Komatsu, ...
PLoS One 9 (6), e100565, 2014
702014
Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis
T Kimura, N Tanaka, N Fujimori, A Sugiura, T Yamazaki, S Joshita, ...
World journal of gastroenterology 24 (13), 1440, 2018
662018
Association between endotoxemia and histological features of nonalcoholic fatty liver disease
H Kitabatake, N Tanaka, N Fujimori, M Komatsu, A Okubo, K Kakegawa, ...
World journal of gastroenterology 23 (4), 712, 2017
592017
Clinical characteristics of young-onset ischemic colitis
T Kimura, A Shinji, A Horiuchi, N Tanaka, T Nagaya, T Shigeno, ...
Digestive diseases and sciences 57, 1652-1659, 2012
542012
Association of IL28B gene polymorphism with development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C virus infection
S Joshita, T Umemura, Y Katsuyama, Y Ichikawa, T Kimura, S Morita, ...
Human immunology 73 (3), 298-300, 2012
542012
Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease
N Fujimori, T Umemura, T Kimura, N Tanaka, A Sugiura, T Yamazaki, ...
World journal of gastroenterology 24 (11), 1239, 2018
522018
Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non‐alcoholic fatty liver disease with none‐to‐mild obesity and liver fibrosis
N Fujimori, N Tanaka, S Shibata, K Sano, T Yamazaki, T Sekiguchi, ...
Hepatology Research 46 (10), 1019-1027, 2016
502016
Clinicopathological characteristics of non‐B non‐C hepatocellular carcinoma without past hepatitis B virus infection
T Kimura, A Kobayashi, N Tanaka, K Sano, M Komatsu, N Fujimori, ...
Hepatology research 47 (5), 405-418, 2017
422017
Serum autotaxin is a useful disease progression marker in patients with primary biliary cholangitis
S Joshita, T Umemura, Y Usami, Y Yamashita, GL Norman, A Sugiura, ...
Scientific Reports 8 (1), 8159, 2018
402018
Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy
T Nagaya, N Tanaka, T Kimura, H Kitabatake, N Fujimori, M Komatsu, ...
BBA clinical 3, 168-174, 2015
382015
Susceptibility of the obese population to COVID-19
T Kimura, H Namkoong
International Journal of Infectious Diseases 101, 380-381, 2020
352020
Serum levels of interleukin‐22 and hepatitis B core‐related antigen are associated with treatment response to entecavir therapy in chronic hepatitis B
S Okuhara, T Umemura, S Joshita, S Shibata, T Kimura, S Morita, ...
Hepatology Research 44 (10), E172-E180, 2014
352014
Metabolic roles of G protein‐coupled receptor signaling in obesity and type 2 diabetes
LF Barella, S Jain, T Kimura, SP Pydi
The FEBS journal 288 (8), 2622-2644, 2021
342021
Metabolic functions of G protein-coupled receptors in hepatocytes—Potential applications for diabetes and NAFLD
T Kimura, SP Pydi, J Pham, N Tanaka
Biomolecules 10 (10), 1445, 2020
342020
Serum cell death biomarkers for prediction of liver fibrosis and poor prognosis in primary biliary cirrhosis
T Sekiguchi, T Umemura, N Fujimori, S Shibata, Y Ichikawa, T Kimura, ...
PloS one 10 (6), e0131658, 2015
322015
Serum thrombospondin 2 is a novel predictor for the severity in the patients with NAFLD
T Kimura, N Tanaka, N Fujimori, T Yamazaki, T Katsuyama, Y Iwashita, ...
Liver International 41 (3), 505-514, 2021
302021
系统目前无法执行此操作,请稍后再试。
文章 1–20